Gene · 2826
Papers2,000
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,000
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| IgA Nephropathy: Current Understanding and Perspectives on Pathogenesis and Targeted Treatment. | Diagnostics (Basel) | 2023 | 36673113 | PubTator, text mining | PubMed |
| Tissue adaptation and clonal segregation of human memory T cells in barrier sites. | Nat Immunol | 2023 | 36658238 | PubTator, text mining | PubMed |
| Distinct early cellular kinetics in participants protected against colonization upon Bordetella pertussis challenge. | J Clin Invest | 2023 | 36649086 | PubTator, text mining | PubMed |
| Recent advances of bioactive proteins/polypeptides in the treatment of breast cancer. | Food Sci Biotechnol | 2023 | 36619215 | PubTator, text mining | PubMed |
| Mahuang Xixin Fuzi decoction protects the BALB/c-nude mice infected with influenza A virus by reducing inflammatory cytokines storm and weakly regulating SIgA immune response. | J Ethnopharmacol | 2023 | 36549371 | PubTator, text mining | PubMed |
| A spatially resolved atlas of the human lung characterizes a gland-associated immune niche. | Nat Genet | 2023 | 36543915 | PubTator, text mining | PubMed |
| High expression of caspase-8 as a predictive factor of poor prognosis in patients with esophageal cancer. | Cancer Med | 2023 | 36533709 | PubTator, text mining | PubMed |
| DNA damage to bone marrow stromal cells by antileukemia drugs induces chemoresistance in acute myeloid leukemia via paracrine FGF10-FGFR2 signaling. | J Biol Chem | 2023 | 36509141 | PubTator, text mining | PubMed |
| Assessing financial factors for oil supply disruptions and its impact on oil supply security and transportation risks. | Environ Sci Pollut Res Int | 2023 | 36484938 | PubTator, text mining | PubMed |
| Distinct T cell subsets in adipose tissue are associated with obesity. | Eur J Immunol | 2023 | 36433684 | PubTator, text mining | PubMed |
| Mitochondrial Uncoupling Induces Epigenome Remodeling and Promotes Differentiation in Neuroblastoma. | Cancer Res | 2023 | 36318118 | PubTator, text mining | PubMed |
| Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer. | FEBS Open Bio | 2023 | 36282125 | PubTator, text mining | PubMed |
| The CCL27-CCR10 axis contributes to promoting proliferation, migration, and invasion of lung squamous cell carcinoma. | Histol Histopathol | 2023 | 36169116 | PubTator, text mining | PubMed |
| Single-cell landscape and clinical outcomes of infiltrating B cells in colorectal cancer. | Immunology | 2023 | 36082430 | PubTator, text mining | PubMed |
| A unique immune signature in blood separates therapy-refractory from therapy-responsive acute graft-versus-host disease. | Blood | 2023 | 36044666 | PubTator, text mining | PubMed |
| Discovery and characterization of tumor antigens in hepatocellular carcinoma for mRNA vaccine development. | J Cancer Res Clin Oncol | 2023 | 36038676 | PubTator, text mining | PubMed |
| Tumor hijacks macrophages and microbiota through extracellular vesicles. | Exploration (Beijing) | 2022 | 37324578 | PubTator, text mining | PubMed |
| Exploring causal correlations between inflammatory cytokines and systemic lupus erythematosus: A Mendelian randomization. | Front Immunol | 2022 | 36741410 | PubTator, text mining | PubMed |
| Overweight/obesity-related transcriptomic signature as a correlate of clinical outcome, immune microenvironment, and treatment response in hepatocellular carcinoma. | Front Endocrinol (Lausanne) | 2022 | 36714595 | PubTator, text mining | PubMed |
| Plasma metabolomics, lipidomics and cytokinomics profiling predict disease recurrence in metastatic colorectal cancer patients undergoing liver resection. | Front Oncol | 2022 | 36713567 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/2826/papers?page=15